Pharmaceuticals

Research on the use of psychedelics in substance abuse treatment is on the rise

bexib
By bexib 0 Min Read

A new grant from the National Institutes of Health will advance research into the role of serotonin 5-HT2A receptors in reducing methamphetamine use.

You Might Also Like

Pharma Pulse 6/12/24: Challenges in oncology trials, the role of AI in patient-pharmacist interactions, and more

Pushing the boundaries to revolutionize chronic inflammation treatment

HCP Access Declines, but Connected Field Engagement Breaks Through: Q&A with Dan Rizzo

Up-and-coming players looking to dominate a vibrant ADC field

Huntington’s disease research and development is picking up after some disappointments

Share This Article
Previous Article Moral equality and emergent morality
Next Article FedNow nears 1,000 financial institutions joining
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Progress of metal cutting technology: Innovative innovation, sustainability, and future labor
Manufacturing
Ceratizit showcases innovation, sustainability and cutting-edge solutions at IMTEX 2025
Manufacturing
Goldman launches an internal GEN AI Assistant with 10K employees
Banking
Taiwan emerges as key player in Indian machine tools market with 20.8% growth
Manufacturing